JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Conference Call and Webcast Today at 4:30 p.m. ET
-
Enanta Pharmaceuticals to Participate in Two Investor Conferences in June
-
Enanta Pharmaceuticals (ENTA) PT Lowered to $73 at JMP Securities, Following Clinical Business Update
-
Enanta Pharmaceuticals to Participate in Two Investor Conferences in June
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2021 with Webcast and Conference Call Today at 4:30 p.m. ET
-
Enanta Pharmaceuticals (ENTA) PT Lowered to $68 at JMP Securities
-
UPDATE: JMP Securities Downgrades Enanta Pharmaceuticals (ENTA) to Market Perform Citing Caution on Competitive Profile of EDP-305
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2019
-
Enanta Pharmaceuticals (ENTA) PT Raised to $129 at JMP Securities
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2018
-
JMP Securities Upgrades Enanta Pharmaceuticals (ENTA) to Market Outperform
-
Enanta Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2016
-
JMP Securities Downgrades Enanta Pharmaceuticals (ENTA) to Market Perform
-
JMP Securities Upgrades Enanta Pharmaceuticals (ENTA) to Market Outperform
-
Enanta Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2015
-
JMP Securities Downgrades Enanta Pharmaceuticals (ENTA) to Market Perform
-
Notable Analyst Rating Changes 04/15: (JCP) (CMG) (UA) Upgraded; (UNTK) (ABX) (PAAS) Downgraded
-
Enanta Pharmaceuticals (ENTA) IPO Has Strong Debut

